These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The questionable use of hormone therapy in advanced carcinoma of the prostate. Murphy GP; Slack NH Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459 [No Abstract] [Full Text] [Related]
8. Experimental and theoretical basis for hormonal treatment of prostatic cancer. Carter HB; Isaacs JT Semin Urol; 1988 Nov; 6(4):262-8. PubMed ID: 3068765 [No Abstract] [Full Text] [Related]
9. Assessment of quality of life in patients with prostate cancer. Fosså SD; Aass N; Opjordsmoen S Semin Oncol; 1994 Oct; 21(5):657-61. PubMed ID: 7524156 [No Abstract] [Full Text] [Related]
11. [First national Enantone Symposium. Progress in therapy of prostatic cancer. Multicenter study: long-term follow-up]. Fornara P Urologe A; 1991 May; 30(3 Suppl):10-2. PubMed ID: 1746070 [No Abstract] [Full Text] [Related]
12. Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials. Nanda A; D'Amico AV BJU Int; 2008 Nov; 102(10):1366-8. PubMed ID: 18778343 [No Abstract] [Full Text] [Related]
13. Metastatic prostate cancer: hormone dependency and therapeutic efficacy of GnRH analogues. Tolis G; Koutsilieris M; Stellos A; Fazekas AT; Klioze S; Yakabow A; Adenauer H Acta Endocrinol Suppl (Copenh); 1984; 265():22-3. PubMed ID: 6437108 [No Abstract] [Full Text] [Related]
17. Neurosurgical management of endocrine dependent neoplasms. Parent AD J Miss State Med Assoc; 1979 Mar; 20(3):45-8. PubMed ID: 84875 [No Abstract] [Full Text] [Related]
18. Prognostic model of event-free survival for patients with androgen-independent prostate carcinoma. Shulman MJ; Benaim EA Cancer; 2005 Jun; 103(11):2280-6. PubMed ID: 15844202 [TBL] [Abstract][Full Text] [Related]
19. Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy. Palma D; Pickles T Cancer; 2008 May; 112(10):2322-3; author reply 2323. PubMed ID: 18327816 [No Abstract] [Full Text] [Related]